BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-2.68%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$17.3B
AUM Growth
+$17.3B
(-6%)
Cap. Flow
-$421M
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
87.61%
Holding
112
New
6
Increased
20
Reduced
13
Closed
5
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$46.9M |
| 2 |
AbCellera Biologics
ABCL
|
$38.8M |
| 3 |
Kymera Therapeutics
KYMR
|
$34.4M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$28.7M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$22.2M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$454M |
| 2 |
Krystal Biotech
KRYS
|
$15.6M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$15M |
| 4 |
FibroGen
FGEN
|
$6.48M |
| 5 |
Verastem
VSTM
|
$5.88M |
Sector Composition
| 1 | Healthcare | 99.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sana Biotechnology
SANA
$759M
| $11.9M | 0.07% |
2,000,000
| – | – |
|
52
Cogent Biosciences
COGT
$1.83B
| $11.6M | 0.07% |
+979,600
| New | +$11.6M |
|
|
PNT
53
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $10.6M | 0.06% |
1,169,103
| – | – |
|
|
ADAP
54
Adaptimmune Therapeutics
ADAP
$13.9M
| $10.1M | 0.06% |
10,969,282
+1,138,405
| +12% | +$1.05M |
|
|
NVTA
55
DELISTED
Invitae Corporation
NVTA
| $10M | 0.06% |
8,881,104
| – | – |
|
|
56
Verastem
VSTM
$585M
| $9.94M | 0.06% |
1,336,485
-24,184,962
| -95% | -$5.88M |
|
57
Geron
GERN
$893M
| $9.83M | 0.06% |
3,061,224
| – | – |
|
58
Heron Therapeutics
HRTX
$204M
| $9.43M | 0.05% |
8,131,678
| – | – |
|
59
Athira Pharma
ATHA
$15.5M
| $9.3M | 0.05% |
3,153,807
+803,452
| +34% | +$2.37M |
|
60
Avidity Biosciences
RNA
$6.12B
| $8.87M | 0.05% |
799,451
-204,600
| -20% | -$2.27M |
|
|
BLUE
61
DELISTED
bluebird bio
BLUE
| $8.22M | 0.05% |
2,499,715
| – | – |
|
62
Fate Therapeutics
FATE
$115M
| $7.96M | 0.05% |
1,671,717
| – | – |
|
63
Allogene Therapeutics
ALLO
$249M
| $7.84M | 0.05% |
1,576,901
| – | – |
|
|
OPT
64
DELISTED
Opthea Limited American Depositary Shares
OPT
| $7.54M | 0.04% |
2,691,391
| – | – |
|
65
Insmed
INSM
$30.3B
| $7.24M | 0.04% |
343,000
| – | – |
|
66
TScan Therapeutics
TCRX
$106M
| $6.96M | 0.04% |
2,784,792
| – | – |
|
|
WHWK
67
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $6.77M | 0.04% |
989,928
| – | – |
|
68
Sera Prognostics
SERA
$129M
| $5.86M | 0.03% |
1,777,435
-11,565
| -0.6% | -$38.1K |
|
69
Alector
ALEC
$282M
| $5.8M | 0.03% |
964,851
| – | – |
|
70
Compass Therapeutics
CMPX
$466M
| $4.95M | 0.03% |
1,557,630
| – | – |
|
71
Natera
NTRA
$23B
| $4.87M | 0.03% |
100,000
| – | – |
|
72
MacroGenics
MGNX
$121M
| $4.78M | 0.03% |
892,579
| – | – |
|
|
MREO
73
Mereo BioPharma
MREO
$275M
| $4.69M | 0.03% |
+3,554,979
| New | +$4.69M |
|
|
ARAV
74
DELISTED
Aravive, Inc. Common Stock
ARAV
| $4.11M | 0.02% |
3,261,224
| – | – |
|
|
AFMD
75
DELISTED
Affimed
AFMD
| $3.95M | 0.02% |
6,596,830
| – | – |
|